Federico Garrido
Granada, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: September 26, 2024
The Challenges of HLA Class I Loss in Cancer Immunotherapy: Facts and Hopes.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 16, 2022
Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes.
Journal: International journal of molecular sciences
Published: May 26, 2021
Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: February 08, 2021
MHC heterogeneity and response of metastases to immunotherapy.
Journal: Cancer metastasis reviews
Published: November 14, 2020
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy.
Journal: Cellular & molecular immunology
Published: October 15, 2020
Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
Journal: Frontiers in immunology
Published: August 19, 2020
Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic Vaccine.
Journal: Cancers
Published: April 05, 2020
Cancer immune escape: MHC expression in primary tumours versus metastases.
Journal: Immunology
Published: June 17, 2019
HLA Class-I Expression and Cancer Immunotherapy.
Journal: Advances in experimental medicine and biology
Published: May 30, 2019
Last Updated: 09/26/2026